Biotech, Clinical trials, Diagnostics, Medicine, Neurosciences, Therapeutics, biochemistry, cell biology, molecular biology, antibodies, gene therapy, molecular diagnostics, proteins, small molecules, stem cells, neurology, antibodies, gene therapy, molecular diagnostics, proteins, small molecules, stem cells
Over 7+ years of experience managing large and complex R&D projects, in both the public and private sector, with a special focus on developing new pharmacological therapies for neurodegenerative diseases.
I began my career in the industry by participating as a shareholder in Neurotec Pharma, a start-up company that implemented a Phase IIa trial for Multiple Sclerosis. After several years in the public sector working as an R&D scientist, I evolved into Management positions at Research Institutes (e.g., as Project Manager Coordinator of European projects). Then, I jumped to work at BioSystems S.A. managing the development of IVD products that were successfully launched to the market. Working in both public and private environments has provided me with a vast understanding of the regulatory aspects of developing R&D projects.
Nowadays, as Project Manager at Minoryx Therapeutics, I am fostering an environment of teamwork and ensuring that strategy is clearly defined and integrated into the clinical program of the company while overseeing performance and budget.
My education includes a PhD in Biomedicine; a MSc in Neuroscience and I am a certified Project Management Professional (PMP®) by the Project Management Institute.